ArteraAI
artera.ai
Actively hiring
Clinical Decision Support
Precision Medicine
Medical AI
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
New Data Highlight Artera's MMAI Consistency Across Diverse Patient Populations at ASTRO 2026
Read more
Report
Investment Reports Andre Esteva Interview
Artera is a precision medicine company developing artificial intelligence tools to support personalized cancer treatment decisions. Its platform analyzes digital pathology images and clinical data to assess patient risk and predict potential treatment ben
Read more
Report
Rethinking ADT: AI Biomarkers in Intermediate-Risk Prostate Cancer
A recently published cost-effectiveness analysis has found that using the ArteraAI Prostate Test to guide androgen deprivation therapy (ADT) decisions in men with intermediate-risk prostate cancer receiving radiotherapy dominates both universal ADT and Na
Read more
Report
Is Your Pathology AI Really Ready?
AI is advancing rapidly in pathology, with new FDA clearances, reimbursement pathways, and growing adoption across health systems. But one critical issue has received far less attention: many hospitals are deploying AI tools without confirming they have b
Read more
Report
Pro access
Upgrade to see all 21 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Financials
Total raised
$20M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2024 | $20M | Details |